$3.49
3.87%
Nasdaq, Wed, Sep 16 2026.
ISIN
US5393192027
Symbol
LIXT

Lixte Biotechnology Holdings Inc Stock price

$3.49
-0.41 10.51% 1M
+0.42 13.68% 6M
-0.44 11.20% YTD
-2.14 38.01% 1Y
+1.62 86.63% 3Y
-17.91 83.69% 5Y
+2.23 176.98% 10Y
-1.01 22.44% 20Y
Nasdaq, Closing price Wed, Sep 16 2026
+0.13 3.87%
ISIN
US5393192027
Symbol
LIXT
Industry

Is Lixte Biotechnology Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
$3.3m
Shares outstanding
11.6m
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
75.9%
Return on Equity
-62.9%
ROCE
-66.2%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | -
EBITDA
-
EBIT
$-6.4m
Net Income
$-7.3m
Free Cash Flow
$-4.3m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-
EBIT
-92.9%
Net Income
-119.5%
Free Cash Flow
-47.3%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
More
EPS
$-0.7
FCF per Share
$-0.4
Short interest
2.2%
Employees
2
Rev per Employee
$0.0

Financial data from Lixte Biotechnology Holdings Inc

Mar '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.89 5.89
92% 92%
-
- Research and Development Expense 0.50 0.50
29% 29%
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -6.39 -6.39
93% 93%
-
Net Profit -7.31 -7.31
120% 120%
-

In millions USD.

Don't miss a Thing! We will send you all news about Lixte Biotechnology Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lixte Biotechnology Holdings Inc Stock News

Neutral
PRNewsWire
2 months ago
Issued on behalf of NOMAD Power Solutions, Inc. (Nasdaq: NMAD), formerly LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) NOMAD Power Solutions, Inc. has completed its corporate name change from LIXTE Biotechnology Holdings, Inc. and begins trading today under the new Nasdaq ticker NMAD, marking its transition into the AI energy infrastructure equipment and services sector following its acquis...
Neutral
GlobeNewsWire
2 months ago
-- New Corporate Identity Reflects Strategic Transition into AI Energy Infrastructure Equipment & Services Sector Following Acquisition of NOMAD Transportable Power Systems -- BOCA RATON, Fla., July 06, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. (“NOMAD” or the “Company”), today announced that it has completed its name change from LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) to N...
Neutral
GlobeNewsWire
3 months ago
-Transaction Transforms LIXTE to New Growth Sector Addressing Multi-Billion-Dollar Market of Mobile, Utility-Grade Battery Energy Storage Systems-                                           -Company Plans Corporate Name Change to NOMAD Power Solutions
More Lixte Biotechnology Holdings Inc News

Company Profile

Lixte Biotechnology Holdings, Inc. engages in the development of drugs for cancer treatment. The firm uses biomarker technology to identify enzyme targets associated with serious common diseases and designs novel compounds to attack those targets. Its product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers, and encompasses two major categories of compounds at various stages of pre-clinical and clinical development that the Company believes have broad therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. The company was founded by John S. Kovach and Robert B. Royds on August 9, 2005 and is headquartered in East Setauket, NY.

Head office United States
CEO Mr. Pursglove
Employees 2
Founded 2005
Website lixte.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today